Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
暂无分享,去创建一个
[1] Matthew J. Moscou,et al. A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.
[2] Carl H. June,et al. Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition , 2016, Clinical Cancer Research.
[3] Christopher M. Vockley,et al. Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.
[4] A. Scharenberg,et al. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template , 2015, Science Translational Medicine.
[5] Detlef Weigel,et al. Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.
[6] R. Maehr,et al. Functional annotation of native enhancers with a Cas9 -histone demethylase fusion , 2015, Nature Methods.
[7] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[8] Hao Yin,et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.
[9] N. Grishin,et al. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action , 2006, Biology Direct.
[10] N. Pavletich,et al. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A , 1991, Science.
[11] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[12] Marcela V Maus,et al. Antibody-modified T cells: CARs take the front seat for hematologic malignancies. , 2014, Blood.
[13] Zengrong Zhu,et al. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. , 2014, Cell stem cell.
[14] Tetsushi Sakuma,et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9 , 2014, Nature Communications.
[15] Martin J. Aryee,et al. GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.
[16] David Baltimore,et al. Chimeric Nucleases Stimulate Gene Targeting in Human Cells , 2003, Science.
[17] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[18] Di Zhang,et al. CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection , 2014, PloS one.
[19] R. Barrangou,et al. Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria , 2012, Proceedings of the National Academy of Sciences.
[20] Baorui Liu,et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients , 2016, Scientific Reports.
[21] Carl H. June,et al. A versatile system for rapid multiplex genome-edited CAR T cell generation , 2017, Oncotarget.
[22] Morgan L. Maeder,et al. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications , 2015, Genome Biology.
[23] Dana Carroll,et al. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. , 2002, Genetics.
[24] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[25] Ronald D. Vale,et al. A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging , 2014, Cell.
[26] Edward M. Callaway,et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration , 2016, Nature.
[27] George M. Church,et al. Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers , 2012, Nucleic acids research.
[28] JoungJ. Keith,et al. Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing , 2015 .
[29] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[30] Michel Sadelain,et al. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor , 2002, Nature Biotechnology.
[31] Jun Zhang,et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting , 2013, Cell Research.
[32] Arthur Weiss,et al. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways , 1991, Cell.
[33] J. Keith Joung,et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs , 2014, Nature Biotechnology.
[34] R. Barrangou,et al. CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes , 2007, Science.
[35] Takashi Yamamoto,et al. Homologous Recombination-Independent Large Gene Cassette Knock-in in CHO Cells Using TALEN and MMEJ-Directed Donor Plasmids , 2015, International journal of molecular sciences.
[36] Michel Sadelain,et al. Safe harbours for the integration of new DNA in the human genome , 2011, Nature Reviews Cancer.
[37] Jong-il Kim,et al. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells , 2015, Nature Methods.
[38] Ronnie J Winfrey,et al. High frequency modification of plant genes using engineered zinc finger nucleases , 2009, Nature.
[39] R. Shattock,et al. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. , 2015, The Journal of general virology.
[40] Wei-Ting Hwang,et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.
[41] J. Orange,et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.
[42] Mithat Gönen,et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection , 2017, Nature.
[43] G. Church,et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.
[44] J. Vogel,et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III , 2011, Nature.
[45] David A. Scott,et al. In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.
[46] I. Pastan,et al. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains , 2009, Proceedings of the National Academy of Sciences.
[47] Jennifer A. Doudna,et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins , 2015, Proceedings of the National Academy of Sciences.
[48] Luigi Naldini,et al. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. , 2012, Blood.
[49] R. Barrangou,et al. CRISPR/Cas, the Immune System of Bacteria and Archaea , 2010, Science.
[50] Erin L. Doyle,et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.
[51] M. Kalos,et al. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. , 2013, Immunity.
[52] Feng Zhang,et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 , 2014, Nature Biotechnology.
[53] J. Doudna,et al. RNA-guided genetic silencing systems in bacteria and archaea , 2012, Nature.
[54] Yu Chen,et al. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection , 2015, Scientific Reports.
[55] Elo Leung,et al. A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.
[56] Fan Yang,et al. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection , 2014, Proceedings of the National Academy of Sciences.
[57] Jean-Paul Concordet,et al. Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair , 2014, Genome research.
[58] Jin-Soo Kim,et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.
[59] Seung Woo Cho,et al. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. , 2009, Genome research.
[60] Gang Bao,et al. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection , 2014, Proceedings of the National Academy of Sciences.
[61] A. Weiss,et al. A CRISPR-Based Toolbox for Studying T Cell Signal Transduction , 2016, BioMed research international.
[62] Morgan L. Maeder,et al. CRISPR RNA-guided activation of endogenous human genes , 2013, Nature Methods.
[63] Jeffry D. Sander,et al. Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.
[64] Dana Carroll,et al. Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells , 2006, Proceedings of the National Academy of Sciences.
[65] Hans Clevers,et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. , 2013, Cell stem cell.
[66] J. Fu,et al. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus , 2015, Gene Therapy.
[67] Israel Steinfeld,et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.
[68] George M. Church,et al. Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9 , 2013, Nature Biotechnology.
[69] Bruno Laugel,et al. Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies , 2013, Front. Immunol..
[70] George M. Church,et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems , 2013, Nucleic acids research.
[71] Daesik Kim,et al. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins , 2014, Genome research.
[72] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[73] David R. Liu,et al. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification , 2014, Nature Biotechnology.
[74] M. Rowicka,et al. Nucleotide-resolution DNA double-strand breaks mapping by next-generation sequencing , 2013, Nature Methods.
[75] Yarden Katz,et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system , 2013, Cell Research.
[76] Jeffrey C. Miller,et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.
[77] T. Hocking,et al. Heritable Targeted Gene Disruption in Zebrafish Using Designed Zinc Finger Nucleases , 2008, Nature Biotechnology.
[78] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[79] Richard L. Frock,et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases , 2014, Nature Biotechnology.
[80] Lei Zhang,et al. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer , 2012, Nature Medicine.
[81] Axel Hoos,et al. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies , 2016, Nature Reviews Drug Discovery.
[82] F. Gleason,et al. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA , 2014 .
[83] David Cyranoski,et al. CRISPR gene-editing tested in a person for the first time , 2016, Nature.
[84] Luke A. Gilbert,et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.
[85] Ron Weiss,et al. Highly-efficient Cas9-mediated transcriptional programming , 2014, Nature Methods.
[86] David Bryder,et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. , 2014, Cell stem cell.
[87] Christopher M. Vockley,et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.
[88] J. Joung,et al. Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing. , 2015, Human gene therapy.
[89] A. Cheng,et al. CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells , 2016, Cell Research.
[90] Meijie Li,et al. A Retroviral CRISPR-Cas9 System for Cellular Autism-Associated Phenotype Discovery in Developing Neurons , 2016, Scientific Reports.
[91] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[92] Aymeric Duclert,et al. Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies. , 2015, Cancer research.
[93] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[94] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[95] Dana Carroll,et al. Enhancing Gene Targeting with Designed Zinc Finger Nucleases , 2003, Science.
[96] Hui Zhao,et al. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair , 2016, Nucleic acids research.
[97] Z. Eshhar,et al. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[98] Jens Boch,et al. Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.
[99] S. Larson,et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 , 2003, Nature Medicine.
[100] David A. Scott,et al. Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.